Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Well differentiated thyroid cancer.

× No keyword cloud information.

14 in total

1. On-site ultrasound-guided localization for impalpable nodal recurrences in papillary thyroid carcinoma patients.

Authors: Kuk-Jin Kim; Bup-Woo Kim; Yong Sang Lee; Hang-Seok Chang; Cheong Soo Park
Journal: J Korean Surg Soc Date: 2013-08-26

Review 2. Papillary thyroid cancer.

Authors: Nadine R Caron; Orlo H Clark
Journal: Curr Treat Options Oncol Date: 2006-07

3. Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation.

Authors: Andreas Hillenbrand; Jan-Erik Varhaug; Michael Brauckhoff; Rumen Pandev; Sabine Haufe; Cornelia Dotzenrath; Roswitha Köberle; Rainer Hoffmann; Günther Klein; Martina Kadmon; Thomas Negele; Tatjana Hagieva; Doris Henne-Bruns; Markus Luster; Theresia Weber
Journal: Langenbecks Arch Surg Date: 2010-08-05 Impact factor: 3.445

4. Association between prognostic factors and clinical outcome of well-differentiated thyroid carcinoma: A retrospective 10-year follow-up study.

Authors: Shangtong Lei; Zihai Ding; Junna Ge; Donghui Zhao
Journal: Oncol Lett Date: 2015-06-24 Impact factor: 2.967

5. RUNX3 site-specific hypermethylation predicts papillary thyroid cancer recurrence.

Authors: Dan Wang; Wei Cui; Xiaoyan Wu; Yiping Qu; Na Wang; Bingyin Shi; Peng Hou
Journal: Am J Cancer Res Date: 2014-11-19 Impact factor: 6.166

6. Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell lines.

Authors: S Hoffmann; A Burchert; A Wunderlich; Y Wang; S Lingelbach; L C Hofbauer; M Rothmund; A Zielke
Journal: Endocrine Date: 2007-04 Impact factor: 3.633

7. Selective modified radical neck dissection for papillary thyroid cancer-is level I, II and V dissection always necessary?

Authors: N R Caron; Y Y Tan; J B Ogilvie; F Triponez; E S Reiff; E Kebebew; Q Y Duh; O H Clark
Journal: World J Surg Date: 2006-05 Impact factor: 3.352

8. Regional metastatic pattern of papillary thyroid carcinoma.

Authors: Imdat Yüce; Sedat Cağli; Ali Bayram; Fatih Karasu; Ercihan Güney
Journal: Eur Arch Otorhinolaryngol Date: 2009-07-08 Impact factor: 2.503

9. Targeting the EGF/VEGF-R system by tyrosine-kinase inhibitors--a novel antiproliferative/antiangiogenic strategy in thyroid cancer.

Authors: S Hoffmann; S Gläser; A Wunderlich; S Lingelbach; C Dietrich; A Burchert; H Müller; M Rothmund; A Zielke
Journal: Langenbecks Arch Surg Date: 2006-10-12 Impact factor: 3.445

10. Hemithyroidectomy increases the risk of disease recurrence in patients with ipsilateral multifocal papillary thyroid carcinoma.

Authors: Xiaolong Li; Cui Zhao; Dandan Hu; Yang Yu; Jin Gao; Wenchuan Zhao; Ming Gao
Journal: Oncol Lett Date: 2013-02-19 Impact factor: 2.967